LATEST ISSUE: Insulin, the next 100 years; diabetes tech update and overview; common digestive disorders
Following last issue’s look at the history of the discovery of insulin, this time we take a good look at what might yet happen. We
Following last issue’s look at the history of the discovery of insulin, this time we take a good look at what might yet happen. We
Tandem is first smartphone App to be cleared for insulin delivery by the FDA on both iOS and Android operating systems. Announced in mid-February 2022,
The American medical devices giant Becton Dickinson known as BD, has decided to spin off its Diabetes Care division and announced the name of the
Latest results from the makers of Revita, the revolutionary ‘intestine resurfacing’ device being proposed as a treatment for T2D, offer a glimmer of light in
A raft of new products to reduce the chore of living with diabetes, are in the pipeline from Dexcom. The innovations called G7, a new
Insulin pump manufacturer Insulet has announced their new Omnipod 5 device has at last received regulatory approval from the American Food and Drug Administration (FDA)
Tandem Diabetes Care has announced that it expects to treble its worldwide customer base to one million people within the next five years, mainly by
Researchers have now homed in on four factors which may trigger the worrying rise in diabetes diagnoses following COVID-19 infection, according to the American Diabetes
Medtronic one of the world’s leading medical device companies, has been hit by a warning letter from the regulatory Food and Drug Administration (FDA) in
As of 100 years ago, a diagnosis of Type 1 diabetes ceased to be a death sentence. Seeing all the coverage of the amazing, life-saving